Quantum biophysical platform for deterministic satiety signaling modulation and metabolic homeostasis in human...

Current translational approaches to obesity and metabolic syndrome predominantly rely on chemical interventions modeled via stochastic passive diffusion. These traditional methods inherently lack spatial targeting and temporal precision, often resulting in delayed therapeutic onset. Here, we present a paradigm shift using a novel quantum biophysical framework that treats the gastrointestinal microenvironment as a non-equilibrium semiconductor network. By engineering a Metabolite Conjugate Prebiotic (MCP) platform with an embedded polyphenolic tannin matrix, we command targeted electron translocation across microbial membranes, establishing a directional "metabolic pull." Validated against a Real-World Evidence (RWE) cohort of 2,000 subjects, this platform demonstrated an accelerated biological response window, achieving rapid and deterministic activation of satiety signaling within 15 to 60 min. Notably, while the FDA recommends 20 to 25 grams per day for traditional prebiotics, participants in this cohort required a significantly minimized dosage of only 2 to 3 grams of MCP per day to elicit these homeostatic effects. The computational framework yields a 92 percent clinical predictive accuracy, significantly outperforming classical stochastic models. This platform offers a scalable, highly predictable avenue for precision translational medicine in metabolic health.